.jpg)
Why NKG Mice Stand Out？
Severe Immunodeficiency
Immunodeficient (T/B/NK-null) – Enhanced human cell engraftment efficiency.
Broad Humanization Compatibility
Compatible with HSCs, PBMCs, PDXs, adult stem cells, and other human tissue engraftment.
Versatile Research Use
Optimized for oncology, autoimmunity, cell therapy, GvHD research, and toxicology
evaluations.
Superior Health Status
To be produced at the same site and health standard as NOG in the US.
Explore Our Free Trial Program
Cyagen is inviting researchers in the US and EU to evaluate our NKG mice at no cost. This limited-time offer supports preclinical studies and fosters collaboration within the biomedical research community.
Application Period: April 25 – June 30, 2025
Eligibility: Researchers in the US or EU
Shipment: Upon eligibility approval and optional MTA confirmation
Response Time: 3–5 business days after submission
Apply for Free Trial
Limited slots available. Applications are reviewed on a rolling
basis.
Maximize Research Potential with More Enhanced Resources
Watch Our Expert Webinar
Advancing Precision Oncology: Immune-Humanized Mice for Preclinical Drug Evaluation
April 24, 2025 | 9:00 AM PDT
Download Our NKG Mouse Brochure
Detailed specifications, validation data, and usage recommendations
FAQ
Who
qualifies for the
free trial?
Researchers in the EU or
US.
Will I
need a
Material Transfer Agreement (MTA)?
Possibly.
We will assist
you with the process if needed.
What
happens after I
submit the form?
We will
review your
application within 3–5 business days and get in touch.
Begin Your Discovery Now
Cyagen is committed to protecting your privacy. The information collected will be used solely for evaluating your eligibility for the NKG Mice Free Trial Program. Your data will not be shared with third parties without consent.
We will review your application and contact you within 3–5 business days.